A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Medicine

Epidemiology

Immunology

Show all topics

DOI

10.1101/2020.08.28.272880

License

CC-BY-ND

Other Formats

PDF